Bicycle Therapeutics Stock Options
| BCYC Stock | USD 9.08 0.41 4.32% |
Bicycle Therapeutics' latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 1.68 with a put-to-call open interest ratio of 0.5 over 22 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on June 20th 2025.
Open Interest Against June 20th 2025 Option Contracts
2025-06-20
The chart above shows Bicycle Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Bicycle Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Bicycle Therapeutics' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Bicycle Therapeutics
Analyzing Bicycle Therapeutics' in-the-money options over time can help investors to take a profitable long position in Bicycle Therapeutics regardless of its overall volatility. This is especially true when Bicycle Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Bicycle Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Bicycle Therapeutics' stock while costing only a fraction of its price.
Bicycle Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Bicycle Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Bicycle stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Bicycle Therapeutics' stock price goes up or down, the stock options follow.
At present, Bicycle Therapeutics' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 1.5 B, whereas Sale Purchase Of Stock is forecasted to decline to about 43.8 M. Bicycle Current Options Market Mood
Bicycle Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Bicycle Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Bicycle Therapeutics' options investors are not very successful. Bicycle Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Bicycle contract
Base on the Rule 16, the options market is currently suggesting that Bicycle Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2025-06-20 option contract. With Bicycle Therapeutics trading at USD 9.08, that is roughly USD 0.009534. If you think that the market is fully incorporating Bicycle Therapeutics' daily price movement you should consider buying Bicycle Therapeutics options at the current volatility level of 1.68%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Bicycle |
Purchasing Bicycle Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Bicycle calls. Remember, the seller must deliver Bicycle Therapeutics stock to the call owner when a call is exercised.
Bicycle Therapeutics Option Chain
When Bicycle Therapeutics' strike price is surpassing the current stock price, the option contract against Bicycle Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Bicycle Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Bicycle. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Bicycle. It also shows strike prices and maturity days for a Bicycle Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | BCYC250620C00040000 | 1 | 40.0 | 0.0 - 4.9 | 1.0 | Out |
Call | BCYC250620C00035000 | 0 | 35.0 | 0.0 - 4.9 | 4.9 | |
Call | BCYC250620C00030000 | 1 | 30.0 | 0.0 - 4.9 | 4.9 | Out |
Call | BCYC250620C00025000 | 37 | 25.0 | 0.0 - 2.0 | 0.2 | Out |
Call | BCYC250620C00022500 | 8 | 22.5 | 0.0 - 4.9 | 0.5 | Out |
Call | BCYC250620C00020000 | 46 | 20.0 | 0.0 - 1.1 | 0.25 | Out |
Call | BCYC250620C00017500 | 45 | 17.5 | 0.0 - 0.85 | 1.5 | Out |
Call | BCYC250620C00015000 | 246 | 15.0 | 0.05 - 4.9 | 0.3 | Out |
Call | BCYC250620C00012500 | 7 | 12.5 | 0.0 - 0.75 | 4.35 | Out |
Call | BCYC250620C00010000 | 26 | 10.0 | 0.0 - 1.75 | 1.0 | Out |
Put | BCYC250620P00040000 | 0 | 40.0 | 28.7 - 32.8 | 28.7 | In |
Put | BCYC250620P00035000 | 0 | 35.0 | 23.8 - 27.8 | 23.8 | In |
Put | BCYC250620P00030000 | 0 | 30.0 | 18.8 - 22.7 | 18.8 | In |
Put | BCYC250620P00025000 | 0 | 25.0 | 14.4 - 17.5 | 14.4 | In |
Put | BCYC250620P00022500 | 0 | 22.5 | 12.1 - 15.1 | 4.99 | In |
Put | BCYC250620P00020000 | 0 | 20.0 | 10.1 - 12.5 | 2.9 | In |
Put | BCYC250620P00017500 | 8 | 17.5 | 7.3 - 9.8 | 3.4 | In |
Put | BCYC250620P00015000 | 45 | 15.0 | 4.6 - 6.7 | 3.42 | In |
Put | BCYC250620P00012500 | 5 | 12.5 | 2.5 - 4.6 | 1.5 | In |
Put | BCYC250620P00010000 | 8 | 10.0 | 0.0 - 2.5 | 1.45 | In |
Put | BCYC250620P00007500 | 89 | 7.5 | 0.0 - 0.5 | 0.27 | Out |
Put | BCYC250620P00005000 | 54 | 5.0 | 0.0 - 0.1 | 0.1 | Out |
Bicycle Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Bicycle Total Stockholder Equity
Total Stockholder Equity |
|
Bicycle Therapeutics Corporate Management
| Kevin MBA | CEO Director | Profile | |
| CBE FMedsci | NonEx CoFounder | Profile | |
| Christian Heinis | Scientific Founder | Profile | |
| Stephanie Yao | Senior Communications | Profile | |
| Alistair Milnes | Chief Officer | Profile | |
| Gillian Langford | Head Management | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicycle Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bicycle Therapeutics. If investors know Bicycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bicycle Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.90) | Revenue Per Share | Quarterly Revenue Growth (0.30) | Return On Assets | Return On Equity |
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bicycle Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bicycle Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bicycle Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.